Background and Aim: Functional dyspepsia (FD ... Gastric mucosa-protecting agents are frequently used to treat dyspepsia that causes heaviness or pain in stomach. Teprenone is one such gastric ...

Objective Functional dyspepsia (FD) is a chronic gastroduodenal disorder. Individuals with FD demonstrate visceral hypersensitivity, abnormal central pain processing, and low mood, but it is unclear ...

Therefore, we believe that the 5-HT 4 agonist, mosapride, can be a first-line drug to treat FD. A long-term study comparing mosapride with placebo would further clarify the effectiveness of mosapride.

Functional dyspepsia (dis-PEP-see-uh) is a kind of upset stomach or indigestion that doesn’t have a definite cause. It’s thought to happen because of a mix of things. Functional dyspepsia is a type of ...

As both existing and novel treatments, including proton pump inhibitors (PPI) and pre- or probiotics may impact duodenal barrier function, it is important to recognize and study these alterations to ...

The reasons for this finding are unknown. Bennett et al. suggest that active promotion of the existing guidelines would improve the first-line management of dyspepsia.

Objective Functional dyspepsia (FD) is a chronic disorder that is difficult to treat. Helicobacter pylori may contribute to its pathophysiology. A Cochrane review from 2006 suggested that eradication ...

200 participants with functional dyspepsia will be randomly assigned to the true acupuncture ... confirming whether individualised acupuncture treatment is efficacious for patients with FD; second, ...

His research interests include identifying novel pathophysiologic mechanisms and treatments for functional dyspepsia and gastroparesis, specifically. In addition to clinical research, Dr. Cangemi has ...

Delaney and colleagues have assessed the relative cost-effectiveness of Helicobacter pylori 'test and treat' or empiric acid suppression for the initial management of patients with dyspepsia.

Houghton, Ph.D., include the causes, pathophysiology, genetics and treatment of functional gastrointestinal disorders (FGIDs), particularly irritable bowel syndrome, functional dyspepsia, functional ...